fbpx

In The News

Brain Photobiomodulation: A Potential Drug-Free Option for Alzheimer’s Therapy

Brain Photobiomodulation: A Drug-Free Alternative for Treating Alzheimer's Disease Alzheimer's disease, a progressive neurodegenerative disorder, poses one of the greatest challenges to modern medicine. With its devastating impact on cognitive function and quality of life, finding effective treatments has become an urgent priority. As traditional pharmacological therapies struggle to provide a definitive cure, alternative [...]

Creativity and Brain Photobiomodulation | Independent Research with Vielight Technology

The Vielight Neuro Gamma was utilized in a study examining the link between creativity and brain photobiomodulation, specifically of the Default Mode Network. This groundbreaking study had 58 healthy participants and was sham-controlled, single-blinded and randomized. Researchers from the University of Deusto, Spain, the University of Montpellier, France and Pennsylvania State University, USA were [...]

40Hz Gamma Neuromodulation in Alzheimer’s Research | Brain Photobiomodulation and Visual Cortex Stimulation

The Ongoing Search for Effective and Accessible Treatments for Alzheimer’s Disease Alzheimer’s disease (AD) is the most common type of dementia in elderly individuals worldwide (Wilson et al., 2012). The disease is characterized by neurodegeneration, tissue changes in the brain, (including amyloid-containing plaques and tangles of hyperphosphorylated tau protein), severe cognitive decline and in [...]

Parkinson’s Disease Clinical Trial Results | Vielight Brain Photobiomodulation Technology

This study was a historical first in showing the potential efficacy of photobiomodulation for Parkinson's symptoms in humans. The Vielight Neuro Gamma was utilized for transcranial-intranasal brain photobiomodulation and an Irradia MID 2.5 laser device for neck and abdominal photobiomodulation throughout this study. Read the full study here: Link Watch the explainer video below. [...]

Autism Photobiomodulation Clinical Trial Results | Vielight Brain Photobiomodulation Technology

At the moment, there are no pharmacological treatments for Autism Spectrum Disorder. There is a growing interest in non-pharmacological approaches, such as brain photobiomodulation. This animation explores the results of an Autism Spectrum Disorder clinical study using the Vielight Neuro Duo, conducted by Dr Stefano Pallanti, a Stanford University Professor and Director of Istituto [...]

Dementia and Brain Photobiomodulation

In 2015, our dementia pilot trial made history by being the first to show efficacy of brain photobiomodulation (PBM) for dementia in humans with a home-use device, the Vielight Neuro Gamma.[1] In 2019, Dr. Linda Chao, a professor in the Departments of Radiology, Biomedical Imaging and Psychiatry at the University of California, verified our [...]

Enhancing the Default Mode Network (DMN)

Many neuroscience publications indicate that the brain is modular and composed of different networks The key to successful brain stimulation (and brain photobiomodulation) is to focus on networks that hold the most importance to your objective. The Default Mode Network (DMN) is a collection of brain regions that are active when an individual is [...]

What are the differences between the Vielight Neuro Alpha and Neuro Gamma devices?

The question, “When should I use an alpha frequency and when should I use a gamma frequency?” is not new. In the context of brain photobiomodulation and Vielight products, this question refers to the Vielight Neuro Alpha and Neuro Gamma devices. More specifically, answering this question requires an understanding of the differences between these [...]